menu

Quintiles Library

Show Filters
Press Release
Read More
Press Release
Read More
Press Release
Read More
Press Release
Read More
Press Release
Read More
Press Release
Read More
Press Release
Read More
Service
Expanding and Optimizing the RBM Model Biopharma is adopting Risk-based Monitoring (RBM) as the standard execution model for clinical studies. As the RBM market leader, Quintiles is leading this evolution. Now, you can gain from our industry-leading RBM approach with a standalone Centralized Monitoring capability, which integrates our operational expertise, data...
Read More
Service
The scope of change is broad and complex Implementing RBM within your clinical operations affects your clinical development staff, but also your partners for site monitoring, data management, medical monitoring.  Managing this change requires an experienced team, careful planning, proven tools and methodology.  Quintiles Change Management –Methodology and Experience We...
Read More
Press Release
RESEARCH TRIANGLE PARK, NC – July 1, 2014 – Quintiles today announced that it has completed the acquisition of Encore Health Resources (Encore), a leader in the health-information analytics and technology consulting services industry focused on healthcare providers. “We are extremely pleased to have completed the acquisition of Encore,” said Scott Evangelista, president,...
Read more
Press Release
READING, UNITED KINGDOM – June 6, 2014 – Quintiles announced today that it has been recognized as one of Europe’s Best Workplaces by the Great Place to Work® Institute, finishing in 24th place in the Best “Multinational Large” Workplace category. Quintiles was also recognized this year in several individual European countries including Germany, Italy, Poland, Spain and...
Read More
Service
Simplify complex outputs Because today’s technology platforms can produce overwhelming amounts of data, sometimes the biggest challenge is just trying to sort through it all and prioritize what's important. When that burden is reduced, vital information becomes more apparent, facilitating better medicine and research. Focus on the right details Quintiles'...
Read More
Service
Genomic Assays for Clinical Development   Insights gleaned from the collection and analysis of genomic data is the foundation of precision medicine.  By offering new insights into disease markers, mechanisms of action, and pathways, drug developers are harnessing genomic information to develop safer more efficacious drugs. At EA|Quintles, our CLIA certified laboratories...
Read More
Service
Simplify management When your study requires a broad array of assays, you may need to work with multiple labs. Sample management, data integrity and operational costs are concerns that increase with each additional external resource. Your strategic advantage is our priority External lab management is a function that—although increasingly necessary—is often characterized...
Read More
Service
You can trust Quintiles to preserve the integrity of your biospecimens for as long as you need to store them. Robust SOPs guide our operation and contingency planning to ensure the highest standards of biopreservation. Our biobank capabilities include: Storage and tracking at multiple temperature levels  Genomic sample banking at -70°C Proactive,...
Read More
Service
Our four assay development laboratories are strategically located in Atlanta, Chicago, Edinburgh and Singapore.  Each central lab is fully equipped with state-of-the-art technologies and standardized instrumentation, and staffed by dedicated teams of scientists. You'll find the R&D support you need:   Expertise in fluid, tissue and cell-based assay development for...
Read More
Service
Complete e-pathology solution – anywhere in the world Whether for product development insights or archival purposes, our digital pathology services offer the reliability, accuracy and convenience you demand: Digital slide scanning hubs in the US, Scotland and China  Available as part of our clinical trials service or as a stand-alone service  20X and 40X...
Read More
Service
Chronic infection with the hepatitis C virus (HCV) affects approximately 150 million people worldwide,1 with approximately 3 million of those in the United States alone.2 Single nucleotide polymorphisms (SNPs) in the IL28B gene are predictors of therapeutic response in patients with HCV3 and are so critical to clinical trial design that testing for IL28B genotype at the...
Read More
Service
Q2 Solutions Central Labs network wholly owned laboratories and affiliate laboratories accredited by the highest industry standards. In fact, all laboratory locations are fully CAP accredited, and we are the first central lab to receive the highest global accreditation of lab quality, ISO 15189, in both the US and Europe.  **Click on agency name to view certification ...
Read More
Service
Data management and transmission when and how you need it Study Start-up Detailed file specifications – standard data files (CDISC) or customized data files Programming standards and validation lifecycle Transmission for CDMS, IVR, Safety Board, etc. Rigorous test transfer and approval process Study Maintenance Customized protocol-specific...
Read More